Effect of Prenatal care upon medical conditions in pregnancy

Prenatal Care ◽  
1999 ◽  
pp. 11-32
Author(s):  
Phillip G. Stubblefield
1986 ◽  
Vol 7 (sup1) ◽  
pp. S17-S17
Author(s):  
F. Polvani ◽  
G. Di Francesco ◽  
P. Capetta ◽  
E. Greco
Keyword(s):  

2018 ◽  
Vol 05 (06) ◽  
Author(s):  
Arnildo Korb ◽  
Saionara Vitoria Barimacker ◽  
Maria Sabrina Telch dos Santos ◽  
Suellen Fincatto ◽  
Carine Vendruscolo ◽  
...  

Medicine ◽  
2016 ◽  
Vol 95 (34) ◽  
pp. e4630 ◽  
Author(s):  
Sang Hyung Lee ◽  
Seung Mi Lee ◽  
Nam Gu Lim ◽  
Hyun Joo Kim ◽  
Sung-Hee Bae ◽  
...  

2020 ◽  
Vol 28 (9) ◽  
pp. 640-643
Author(s):  
Alison Gabrielle Perry ◽  
Anna Merrick

The stories of our lives that bring each of us to a career in midwifery are unique. The stories, once we are midwives, that then influence our careers, are also unique. These stories of care for women characterise the course of our careers and ourselves. A short essay competition to attend the annual Medical Complications in Pregnancy conference 2019 at the Royal College of Obstetricians and Gynaecologists gave two colleagues from London the occasion to reflect on situations from practice where childbirth deviated from the realm of ‘normal’ and into disease. As we become increasingly floored by the global COVID-19 pandemic, the key role of midwives across health, well-being as well as disease is especially stark.


2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S167-S167
Author(s):  
Tripti Adhikari ◽  
Rachel Scott ◽  
Utsav Timalsina ◽  
Ariunzaya Amgalan ◽  
Shari L Sawney ◽  
...  

Abstract Background Prevalence of HCV in pregnancy is 0.1–3.6%. AASLD and IDSA now recommend HCV screening in pregnancy although CDC, USPSTF, or ACOG still do not—though HCV can be perinatally transmitted and carries associated complications for the mother and fetus. Our study objectives were to analyze prenatal HCV screening practices at a large regional healthcare system and the prevalence of HCV-associated maternal and fetal/neonatal outcomes. Methods We performed a nested propensity score (PS) case–control study of pregnant women who tested HCV Ab+ in a cross-sectional study of women presenting for prenatal care at a large regional healthcare system from January 17 to December 18. We collected retrospective EHR data, including state of residency, HCV Ab, RNA, care engagement, HCV risk factors, comorbidities, maternal and fetal/neonatal morbidity, and neonatal HCV testing (when available). Mixed and generalized linear models were used to examine differences in continuous and categorical variables, respectively, between cases and controls Results 14,363 women were seen for prenatal care; 4,891 (34%) were HCV tested, 75 (1.5%) tested HCV Ab+. Demographic and comorbidity data are shown in Table 1. HCV Ab+ cases had more co-morbidities, including obesity, heart disease, opioid use, and behavioral health issues compared with the controls. HCV risk factors included IVDU (64%) and tattoos (24%) (Figure 1). Neither past/current pregnancy-related complications nor fetal or neonatal adverse events (Figure 2) were statistically significantly different except for cholestasis in HCV Ab+ cases (5.3 vs. 0%, P = 0.04). Conclusion Our study showed only one-third of pregnant women are currently HCV screened in our health system. Universal screening would likely increase the number of HCV-infected women identified. Early HCV detection, repeated testing, and behavioral health intervention of those at high-risk may decrease further horizontal and vertical transmission of HCV in pregnancy. Disclosures All authors: No reported disclosures.


2016 ◽  
Vol 10 (1) ◽  
pp. 40-42 ◽  
Author(s):  
Adam D Jakes ◽  
Ingrid Watt-Coote ◽  
Matthew Coleman ◽  
Catherine Nelson-Piercy

The UK confidential enquiry into maternal deaths identified poor management of medical problems in pregnancy to be a contributory factor to a large proportion of indirect maternal deaths. Maternal (obstetric) medicine is an exciting subspecialty that encompasses caring for both women with pre-existing medical conditions who become pregnant, as well as those who develop medical conditions in pregnancy. Obstetrics and gynaecology trainees have some exposure to maternal medicine through their core curriculum and can then complete an advanced training skills module, subspecialise in maternal–fetal medicine or take time out to complete the Royal College of Physicians membership examination. Physician training has limited exposure to medical problems in pregnancy and has therefore prompted expansion of the obstetric physician role to ensure physicians with adequate expertise attend joint physician–obstetrician clinics. This article describes the role of an obstetric physician in the UK and the different career pathways available to physicians and obstetricians interested in maternal medicine.


Sign in / Sign up

Export Citation Format

Share Document